1. Home
  2. CGTX vs FCAP Comparison

CGTX vs FCAP Comparison

Compare CGTX & FCAP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CGTX
  • FCAP
  • Stock Information
  • Founded
  • CGTX 2007
  • FCAP 1891
  • Country
  • CGTX United States
  • FCAP United States
  • Employees
  • CGTX N/A
  • FCAP N/A
  • Industry
  • CGTX Biotechnology: Pharmaceutical Preparations
  • FCAP Savings Institutions
  • Sector
  • CGTX Health Care
  • FCAP Finance
  • Exchange
  • CGTX Nasdaq
  • FCAP Nasdaq
  • Market Cap
  • CGTX 126.2M
  • FCAP 125.9M
  • IPO Year
  • CGTX 2021
  • FCAP 1999
  • Fundamental
  • Price
  • CGTX $1.70
  • FCAP $46.35
  • Analyst Decision
  • CGTX Strong Buy
  • FCAP
  • Analyst Count
  • CGTX 3
  • FCAP 0
  • Target Price
  • CGTX $2.83
  • FCAP N/A
  • AVG Volume (30 Days)
  • CGTX 3.3M
  • FCAP 5.1K
  • Earning Date
  • CGTX 11-12-2025
  • FCAP 10-24-2025
  • Dividend Yield
  • CGTX N/A
  • FCAP 2.54%
  • EPS Growth
  • CGTX N/A
  • FCAP 9.31
  • EPS
  • CGTX N/A
  • FCAP 3.93
  • Revenue
  • CGTX N/A
  • FCAP $44,673,000.00
  • Revenue This Year
  • CGTX N/A
  • FCAP N/A
  • Revenue Next Year
  • CGTX N/A
  • FCAP N/A
  • P/E Ratio
  • CGTX N/A
  • FCAP $11.79
  • Revenue Growth
  • CGTX N/A
  • FCAP 9.48
  • 52 Week Low
  • CGTX $0.22
  • FCAP $28.50
  • 52 Week High
  • CGTX $3.83
  • FCAP $53.85
  • Technical
  • Relative Strength Index (RSI)
  • CGTX 52.47
  • FCAP 61.08
  • Support Level
  • CGTX $1.29
  • FCAP $44.20
  • Resistance Level
  • CGTX $1.61
  • FCAP $48.25
  • Average True Range (ATR)
  • CGTX 0.14
  • FCAP 0.98
  • MACD
  • CGTX -0.01
  • FCAP -0.04
  • Stochastic Oscillator
  • CGTX 93.62
  • FCAP 55.92

About CGTX Cognition Therapeutics Inc.

Cognition Therapeutics Inc is a clinical-stage biopharmaceutical company engaged in the discovery and development of, small-molecule therapeutics targeting age-related degenerative diseases and disorders of the central nervous system and retina. Its product candidate CT1812, is an orally delivered, small-molecule antagonist designed to penetrate the blood-brain barrier and bind selectively to the S2R complex.

About FCAP First Capital Inc.

First Capital Inc is the financial holding company of First Harrison Bank. Through its subsidiary, it operates as a federally-chartered savings bank that provides banking services to individuals and business customers across locations in America. The bank offers various loans which include residential loans, construction loans, commercial real estate loans and commercial business loans. It also provides consumer loans such as home equity and second mortgage loans, and automobile and truck loans.

Share on Social Networks: